切换至 "中华医学电子期刊资源库"

中华普通外科学文献(电子版) ›› 2020, Vol. 14 ›› Issue (01) : 10 -13. doi: 10.3877/cma.j.issn.1674-0793.2020.01.004

所属专题: 文献

论著

粒细胞巨噬细胞集落刺激因子抑制氟尿嘧啶诱导的胃癌细胞凋亡增强耐药性的实验研究
常仕林1, 何进鹏2, 陈亚琼3, 蔡辉4,()   
  1. 1. 750004 银川,宁夏医科大学
    2. 730013 兰州,中国科学院兰州分院空间辐射生物学实验室
    3. 730013 兰州,甘肃省人民医院医务处
    4. 730013 兰州,甘肃省人民医院普外科
  • 收稿日期:2019-08-19 出版日期:2020-02-01
  • 通信作者: 蔡辉

Granulocyte macrophage colony stimulating factor enhancing drug resistance of gastric cancer cells by inhibiting apoptosis

Shilin Chang1, Jinpeng He2, Yaqiong Chen3, Hui Cai4,()   

  1. 1. Ningxia Medical University, Yinchuan 750004, China
    2. Laboratory of Space Radiation Biology, Lanzhou Branch of Chinese Academy ofSciences, Lanzhou 730013, China
    3. Medical Office, Gansu Provincial People’s Hospital, Lanzhou 730013, China
    4. Department of General Surgery, Gansu Provincial People’s Hospital, Lanzhou 730013, China
  • Received:2019-08-19 Published:2020-02-01
  • Corresponding author: Hui Cai
  • About author:
    Corresponding author: Cai Hui, Email:
引用本文:

常仕林, 何进鹏, 陈亚琼, 蔡辉. 粒细胞巨噬细胞集落刺激因子抑制氟尿嘧啶诱导的胃癌细胞凋亡增强耐药性的实验研究[J]. 中华普通外科学文献(电子版), 2020, 14(01): 10-13.

Shilin Chang, Jinpeng He, Yaqiong Chen, Hui Cai. Granulocyte macrophage colony stimulating factor enhancing drug resistance of gastric cancer cells by inhibiting apoptosis[J]. Chinese Archives of General Surgery(Electronic Edition), 2020, 14(01): 10-13.

目的

通过检测粒细胞巨噬细胞集落刺激因子(GM-CSF)对氟尿嘧啶(5-FU)诱导后胃癌细胞凋亡的影响,初步探讨GM-CSF参与胃癌细胞耐药性的相关机制。

方法

体外培养胃癌SGC7901细胞,MTT法检测5-FU作用于胃癌细胞的半致死剂量;将GM-CSF添加到5-FU处理的胃癌细胞中,MTT法和平板克隆实验检测其对细胞活性和克隆增殖的影响,Annexin V-FITC/PI双染法流式细胞术检测细胞凋亡情况。Western blotting检测凋亡相关蛋白Bax和Bcl-2的表达差异。

结果

5-FU对胃癌细胞的半致死剂量为(16±0.4)mg/L。5-FU对胃癌细胞的活性和增殖能力有明显的抑制作用,GM-CSF能有效减弱5-FU的抑制效果(P<0.05)。5-FU能显著诱导胃癌细胞凋亡,Bax/Bcl-2比值显著升高,而加入GM-CSF后,5-FU诱导的凋亡被抵抗,Bax/Bcl-2比值升高趋势被抑制(P<0.05)。

结论

GM-CSF能够促进胃癌细胞增殖并有效抑制5-FU诱导的胃癌细胞凋亡,在增强胃癌细胞化疗耐药性方面具有重要作用。

Objective

By detecting the effects of granulocyte macrophage colony stimulating factor (GM-CSF) on the apoptosis of gastric cancer cells induced by fluorouracil (5-FU), the mechanism of GM-CSFinvolved in drug resistance of gastric cancer cells was preliminarily explored.

Methods

The gastric cancer SGC7901 cells were cultured in vitro, and the semi-lethal dose of 5-FU on gastric cancer cells was detected by MTT assay. GM-CSF was added to 5-FU-treated gastric cancer cells. The effects of cell proliferation and clonal proliferation were detected by MTT and plate cloning assay. Apoptosis was detected by Annexin V-FITC/PI flow cytometry. Western blotting was used to detect the expression differences of apoptosis-related proteins Bax and Bcl-2.

Results

The semi-lethal dose of 5-FU to gastric cancer cells was (16±0.4) mg/L.5-FU could inhibit the activity and proliferation of gastric cancer cells, which could be effectively weakened by GM-CSF (P<0.05). 5-FU induced apoptosis of gastric cancer cells significantly, Bax/Bcl-2 ratio was significantly increased, while GM-CSF could reverse these trend (P<0.05).

Conclusion

GM-CSF can promote the proliferation of gastric cancer cells and effectively inhibit the apoptosis of gastric cancer cells induced by 5-FU, and plays an important role in enhancing the chemoresistance of gastric cancer cells.

图2 不同处理方式对胃癌SGC7901细胞活性和细胞增殖的影响 A为MTT法检测各组细胞活性率结果,与对照组相比,*P<0.05;联合组与5-FU诱导组相比,*P<0.05。B为克隆形成率,与对照组相比,*P<0.05,**P<0.01;联合组与5-FU诱导组相比,*P<0.05。C为平板克隆实验结果图片;a为空白对照组;b为GM-CSF刺激组;c为5-FU诱导组;d为联合组
图3 倒置相差显微镜下观察四组细胞凋亡情况
图4 不同处理方式对胃癌SGC7901细胞凋亡影响的结果 A为Annexin-V检测细胞凋亡结果;B为四组细胞凋亡率比较,与对照组比较,*P<0.05;联合组与5-FU诱导组相比,*P<0.05
图5 不同处理方式对胃癌SGC7901细胞Bax、Bcl-2蛋白表达的影响 A为各组Bax、Bcl-2蛋白表达结果;B为各组Bax/Bcl-2比值结果;与对照组相比,*P<0.05;联合组与5-FU诱导组相比,*P<0.05
[1]
Nantajit D, Lin D, Li JJ. The network of epithelial-mesenchymal transition: potential new targets for tumor resistance[J]. J Cancer Res Clin Oncol, 2015, 141(10): 1697-1713.
[2]
Metcalf D. The colony-stimulating factors and cancer[J]. Nat Rev Cancer, 2010, 10(6): 425-434.
[3]
Thorn M, Guha P, Cunetta M, et al. Tumor-associated GM-CSF overexpression induces immunoinhibitory molecules via STAT3 in myeloid-suppressor cells infiltrating liver metastases[J]. Cancer Gene Ther, 2016, 23(6): 188-198.
[4]
Liu Q, Qiao L, Hu P, et al. The effect of granulocyte and granulocyte-macrophage colony stimulating factors on tumor promotion[J]. J BUON, 2017, 22(1): 21-28.
[5]
Aliper AM, Frieden-Korovkina VP, Buzdin A, et al. A role for G-CSF and GM-CSF in nonmyeloid cancers[J]. Cancer Med, 2014, 3(4): 737-746.
[6]
Vilalta M, Brune J, Rafat M, et al. The role of granulocyte macrophage colony stimulating factor (GM-CSF) in radiation-induced tumor cell migration[J]. Clin Exp Metastasis, 2018, 35(4): 247-254.
[7]
丁欣. KRAS突变型结肠癌化疗耐药的新机制[D]. 合肥:安徽医科大学, 2018.
[8]
Janik JE, Miller LL, Korn EL, et al. A prospective randomized phase trial of GM-CSF priming to prevent topotecan-induced neutropenia in chemotherapy-naive patients with malignant melanoma or renal cell carcinoma[J]. Blood, 2001, 97(7): 1942-1946.
[9]
Thongprasert S. Phase study of ifosfamide, carboplatin, etoposide and GM-CSF in small cell lung cancer[J]. J Med Assoc Thai, 2000, 83(5): 549-553.
[10]
Charrier S, Chollet P, Bay JO, et al. Hematological recovery and peripheral blood progenitor cell mobilization after induction chemotherapy and GM-CSF plus G-CSF in breast cancer[J]. Bone Marrow Transplant, 2000, 25(7): 705-710.
[11]
Hong IS. Stimulatory versus suppressive effects of GM-CSF on tumor progression in multiple cancer types[J]. Exp Mol Med, 2016, 48(7): e242.
[12]
王一. 粒细胞-巨噬细胞集落刺激因子(GM-CSF)和白介素(IL)-1β在慢性肠炎恶性转化中的作用及机制研究[D]. 北京:中国人民解放军军事医学科学院, 2014.
[13]
Xie Q, Wu MY, Zhang DX, et al. Synergistic anticancer effect of exogenous wild-type p53 gene combined with 5-FU in human colon cancer resistant to 5-FU in vivo[J]. World J Gastroenterol, 2016, 22(32): 7342-7352.
[14]
Revoltella RP, Menicagli M, Campani D. Granulocyte-macrophage colony-stimulating factor as an autocrine survival-growth factor in human gliomas[J]. Cytokine, 2012, 57(3): 347-359.
[15]
Wang H, Li H, Chen F, et al. Baicalin extracted from Huangqin (Radix Scutellariae Baicalensis) induces apoptosis in gastric cancer cells by regulating B cell lymphoma(Bcl-2)/Bcl-2-associated X protein and activating caspase-3 and caspase-9[J]. J Tradit Chin Med, 2017, 37(2): 229-225.
[16]
Ye W, Li Y, Fan L, et al. Effect of annexin A7 suppression on the apoptosis of gastric cancer cells[J]. Mol Cell Biochem, 2017, 429(1-2): 33-43.
[1] 孔莹莹, 谢璐涛, 卢晓驰, 徐杰丰, 周光居, 张茂. 丁酸钠对猪心脏骤停复苏后心脑损伤的保护作用及机制研究[J]. 中华危重症医学杂志(电子版), 2023, 16(05): 355-362.
[2] 张晓燕, 肖东琼, 高沪, 陈琳, 唐发娟, 李熙鸿. 转录因子12过表达对脓毒症相关性脑病大鼠大脑皮质的保护作用及其机制[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(05): 540-549.
[3] 李越洲, 张孔玺, 李小红, 商中华. 基于生物信息学分析胃癌中PUM的预后意义[J]. 中华普通外科学文献(电子版), 2023, 17(06): 426-432.
[4] 张俊, 罗再, 段茗玉, 裘正军, 黄陈. 胃癌预后预测模型的研究进展[J]. 中华普通外科学文献(电子版), 2023, 17(06): 456-461.
[5] 闫笑生, 郑智, 翟育豪, 张海翘, 王鈢, 刘小野, 尹杰, 张军. Borrmann Ⅳ型胃癌临床诊断、病理特征及预后分析[J]. 中华普通外科学文献(电子版), 2023, 17(05): 346-351.
[6] 王龙彪, 刘洪, 董天雄. 中心体扩增细胞占比和C反应蛋白-白蛋白比值对胃癌根治术治疗预后的预测价值[J]. 中华普通外科学文献(电子版), 2023, 17(05): 352-356.
[7] 莫波, 王佩, 王恒, 何志军, 梁俊, 郝志楠. 腹腔镜胃癌根治术与改良胃癌根治术治疗早期胃癌的疗效[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 644-647.
[8] 陈大敏, 曹晓刚, 曹能琦. 肥胖对胃癌患者手术治疗效果的影响研究[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 651-653.
[9] 王鸿彬, 何晓, 吴菁宙. 腹腔镜近端胃切除术中背驮式间置空肠单通道重建术在AEG手术的安全性及抗反流效果研究[J]. 中华普外科手术学杂志(电子版), 2023, 17(05): 526-529.
[10] 宋钰, 赵阳, 王惠君, 廖新华. 术前BMI与可切除胃癌患者术后远期生存的关系[J]. 中华普外科手术学杂志(电子版), 2023, 17(05): 530-533.
[11] 高静, 严学倩, 及月茹, 郝淼旺, 刘苍春. 胃癌患者以慢性贫血为首发表现的高危因素Logistic分析[J]. 中华普外科手术学杂志(电子版), 2023, 17(05): 534-537.
[12] 张彬, 贾贵清, 吴东松, 曹绿洲, 张焰凌, 黄灏, 赵高平. 早期胃癌保功能手术治疗13例病例分析[J]. 中华普外科手术学杂志(电子版), 2023, 17(05): 575-579.
[13] 徐瑜杰, 赵国栋. 晚期胃癌治疗方法的研究进展和挑战[J]. 中华普外科手术学杂志(电子版), 2023, 17(04): 451-455.
[14] 于迪, 于海波, 吴焕成, 李玉明, 苏彬, 陈馨. 发状分裂相关增强子1差异表达对胆固醇刺激下血管内皮细胞的影响[J]. 中华脑科疾病与康复杂志(电子版), 2023, 13(05): 264-270.
[15] 邱甜, 杨苗娟, 胡波, 郭毅, 何奕涛. 亚低温治疗脑梗死机制的研究进展[J]. 中华脑血管病杂志(电子版), 2023, 17(05): 518-521.
阅读次数
全文


摘要